Increasing incidence of HIV ‐ associated tuberculosis in Romanian injecting drug users
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - February 21, 2018 Category: Infectious Diseases Source Type: research
---
HIV Medicine, Ahead of Print. (Source: HIV Medicine)
Source: HIV Medicine - February 21, 2018 Category: Infectious Diseases Source Type: research
---
HIV Medicine,Volume 19, Issue 3, Page 1-2, March 2018. (Source: HIV Medicine)
Source: HIV Medicine - February 21, 2018 Category: Infectious Diseases Source Type: research
Issue Information
(Source: HIV Medicine)
Source: HIV Medicine - February 21, 2018 Category: Infectious Diseases Tags: Issue Information Source Type: research
HIV: ageing, cognition and neuroimaging at 4 ‐year follow‐up
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - February 14, 2018 Category: Infectious Diseases Source Type: research
---
HIV Medicine, Ahead of Print. (Source: HIV Medicine)
Source: HIV Medicine - February 14, 2018 Category: Infectious Diseases Source Type: research
Long ‐term effectiveness of recommended boosted protease inhibitor‐based antiretroviral therapy in Europe
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - February 1, 2018 Category: Infectious Diseases Source Type: research
---
HIV Medicine, Ahead of Print. (Source: HIV Medicine)
Source: HIV Medicine - February 1, 2018 Category: Infectious Diseases Source Type: research
HIV: ageing, cognition and neuroimaging at 4 ‐year follow‐up
ConclusionsIn the present study, we found some evidence for accelerated ageing in HIV‐positive individuals, with a statistically significant HIV status by age group interaction in global cognition, although this interaction could not be explained by the imaging findings. Moreover, we also found that change in cognitive performance was correlated with change in the DTI measures, and this effect was stronger for the HIV‐positive participants. This will need replication in larger studies using a similarly lengthy follow‐up period. (Source: HIV Medicine)
Source: HIV Medicine - February 1, 2018 Category: Infectious Diseases Authors: BI Haynes, M Pitkanen, R Kulasegaram, SJ Casey, M Schutte, K Towgood, B Peters, GJ Barker, MD Kopelman Tags: Original Research Source Type: research
Long ‐term effectiveness of recommended boosted protease inhibitor‐based antiretroviral therapy in Europe
ConclusionsAlthough confounding by indication and calendar year cannot be completely ruled out, in ART‐experienced subjects the long‐term effectiveness of DRV/r‐containing regimens appears to be greater than that of ATZ/r and LPV/r. (Source: HIV Medicine)
Source: HIV Medicine - February 1, 2018 Category: Infectious Diseases Authors: JR Santos, A Cozzi ‐Lepri, A Phillips, S De Wit, C Pedersen, P Reiss, A Blaxhult, A Lazzarin, M Sluzhynska, C Orkin, C Duvivier, J Bogner, P Gargalianos‐Kakolyris, P Schmid, G Hassoun, I Khromova, M Beniowski, V Hadziosmanovic, D Sedlacek, R Paredes, Tags: Original Research Source Type: research
An outbreak of acute hepatitis A among young adult men: clinical features and HIV coinfection rate from a large teaching hospital in Rome, Italy
ConclusionsIn 2016–2017, we saw a rise in the number of hepatitis A cases, with a higher prevalence of adult male patients. No significant differences regarding the prevalence of HIV coinfection emerged. (Source: HIV Medicine)
Source: HIV Medicine - January 30, 2018 Category: Infectious Diseases Authors: A Ciccullo, R Gagliardini, G Baldin, A Borghetti, D Moschese, A Emiliozzi, F Lombardi, R Ricci, D Speziale, F Pallavicini, S Di Giambenedetto Tags: Original Research Source Type: research
An outbreak of acute hepatitis A among young adult men: clinical features and HIV coinfection rate from a large teaching hospital in Rome, Italy
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - January 29, 2018 Category: Infectious Diseases Source Type: research
---
HIV Medicine, Ahead of Print. (Source: HIV Medicine)
Source: HIV Medicine - January 29, 2018 Category: Infectious Diseases Source Type: research
Rates of sustained virological response 12 weeks after the scheduled end of direct‐acting antiviral (DAA)‐based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy?
ConclusionsWe found high SVR12 rates in monoinfected as well as coinfected individuals. No differences were detected between the two subgroups regardless of whether there was accompanying liver cirrhosis or a shortened treatment duration. (Source: HIV Medicine)
Source: HIV Medicine - January 25, 2018 Category: Infectious Diseases Authors: J Bischoff, S Mauss, C Cordes, T Lutz, S Scholten, A Moll, H J äger, M Cornberg, MP Manns, A Baumgarten, JK Rockstroh Tags: Original Research Source Type: research
Cerebrospinal fluid HIV RNA in persons living with HIV
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - January 25, 2018 Category: Infectious Diseases Source Type: research
